Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)

icon1
USD 7.56 BN
MARKET SIZE, 2030
icon2
CAGR 14.7%
(2025-2030)
icon3
514
REPORT PAGES
icon4
718
MARKET TABLES

OVERVIEW

single-cell-analysis-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The single-cell analysis market is projected to reach USD 7.56 billion by 2030 from USD 3.81 billion in 2025 at a CAGR of 14.7% from 2025 to 2030. The market growth is driven by various factors such as the technological advancements in single-cell analysis products, rising prevalence of cancer, increasing R&D in pharmaceutical & biotechnology industries, growth in stem cell research, and growing focus on personalized medicine.

KEY TAKEAWAYS

  • BY REGION
    The North America single-cell analysis market dominated, with a share of 43.1% in 2024. The large share of North America in this market can be attributed to the presence of key market players, as well as growth in the pharmaceutical and biotechnology industries in the region.
  • BY PRODUCT
    By product, the consumables segment is expected to dominate the market, growing at the highest CAGR of 15.7%. The wide applications of consumables in research and genetic exploration, exosome analysis, and the isolation of RNA and DNA are expected to drive growth in this segment.
  • BY TECHNIQUE
    By technique, the flow cytometry segment is expected to dominate the market, with a share of 29.0% in 2024. The large share of this segment can be attributed to the growing prevalence of cancer and rapid innovations in flow cytometry techniques.
  • BY APPLICATION
    By application, the research applications segment is expected to dominate the market, growing at the highest CAGR of 15.6%. Increasing government initiatives related to stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of this application segment.
  • COMPETITIVE LANDSCAPE
    BD (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), 10x Genomics (US), and Merck KGaA (Germany) were identified as Star players in the single-cell analysis market, as they have focused on innovation and expansion of their product portfolios.

The single-cell analysis market is projected to grow significantly over the next decade, driven by various factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The single-cell analysis market is shifting from traditional methods such as flow cytometry and qPCR toward new revenue sources including single-cell sequencing, multi-omics integration, and AI-based bioinformatics. This transition is expanding applications in precision medicine, immuno-oncology, and regenerative biology. Academic institutions, biopharmaceutical companies, and diagnostic laboratories are adopting automated and cloud-based workflows to improve assay reproducibility, enable data integration, and support disease modeling. These changes are driving faster drug discovery, improved diagnostic accuracy, and reduced research and development costs.

single-cell-analysis-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Technological advancements in single-cell analysis products
  • Rising prevalence of cancer
RESTRAINTS
Impact
Level
  • High cost of single-cell analysis products
OPPORTUNITIES
Impact
Level
  • Rising potential in emerging Asian markets
  • High growth potential of single-cell sequencing
CHALLENGES
Impact
Level
  • Lack of standardization in protocols and quality control procedures
  • Technical limitations of single cell analysis

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Technological advancements in single-cell analysis products

Continuous developments in single-cell sequencing, microfluidics, and multi-omics platforms are improving data accuracy and throughput. These advancements are expanding research applications across genomics, transcriptomics, and proteomics, supporting broader adoption in precision medicine, immunology, and developmental biology.

Restraint: High cost of single-cell analysis products

The high cost of instruments, reagents, and data analysis tools limits adoption, especially among small research institutions and laboratories. The need for specialized infrastructure and skilled personnel further increases operational expenses, restraining market growth.

Opportunity: Rising potential in emerging Asian markets

Expanding life sciences research infrastructure and increased funding for genomics and precision medicine in countries such as China, India, and South Korea are creating significant growth opportunities. Growing collaborations and government initiatives are driving regional market expansion.

Challenge: Lack of standardization in protocols and quality control procedures

The absence of uniform protocols and quality control standards across laboratories leads to variability in data interpretation. This lack of standardization hampers reproducibility and cross-study comparison, posing a key challenge to the broader adoption of single-cell analysis technologies.

single-cell-analysis-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Applied optimized single-cell workflows, including dead cell removal and single-cell RNA-seq, to profile rare cell populations in low-viability tumor samples using the 10x Genomics Chromium platform. Enabled robust detection of rare cell types, enhanced reliability for gene expression in challenging patient samples, and accelerated cancer research and drug development.
Employed single-cell RNA sequencing (scRNA-seq) to examine cellular diversity within renal cell carcinoma (RCC) and neurodegenerative disease models. Enabled high-throughput image classification with improved consistency, reduced screening costs, and accelerated phenotypic drug discovery. Achieved high accuracy and enhanced integration of HCS data with omics-based models.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The single-cell analysis market ecosystem includes raw material suppliers (Hamamatsu, Alluxa), product manufacturers (Thermo Fisher Scientific, Danaher), regulatory bodies (FDA, EMA), and end users (Columbia University, University of Manchester). Raw material suppliers provide essential optical and photonic components, while manufacturers develop instruments, reagents, and consumables. Regulatory agencies ensure data reliability and compliance, while academic and clinical end users drive adoption for genomics, immunology, and precision medicine applications, advancing single-cell research and translational outcomes.

single-cell-analysis-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

single-cell-analysis-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Single-cell Analysis Market, By Product

In 2024, the consuambles segment accounted for the largest share of the single-cell analysis market. The large share of this segment can be attributed to the more frequent purchase of these products compared to instruments, which are considered a one-time investment.

Single-cell Analysis Market, By Application

In 2024, the research applications segment accounted for the largest share of the single-cell analysis market. The large share of this segment can be attributed to the increasing government initiatives related to stem cell research and the wide usage of single-cell analysis in cancer research.

Single-cell Analysis Market, By End User

In 2024, the academic & research laboratories segment accounted for the largest share of the single-cell analysis market. The large share of this segment can be attributed to the increasing funding for life science research and the growing number of R&D facilities being set up globally.

REGION

Asia Pacific to be fastest-growing region in global single-cell analysis market during forecast period

The Asia Pacific single-cell analysis market is expected to register the highest CAGR during the forecast period, primarily due to the high prevalence of chronic disorders such as cancer and the growing geriatric population in the region.

single-cell-analysis-market Region

single-cell-analysis-market: COMPANY EVALUATION MATRIX

Becton, Dickinson and Company (Star) maintains a leading position in the single-cell analysis market, supported by a comprehensive portfolio of instruments, reagents, and software solutions for cell isolation, sorting, and characterization. The company focuses on advancing flow cytometry, microfluidics, and multi-omics technologies to enable applications in immunology, oncology, and precision medicine. BD's global presence, strategic collaborations, and continuous R&D investment reinforce its role in driving innovation and adoption of single-cell solutions. QIAGEN (Emerging Leader) is strengthening its market position through integrated sample preparation and nucleic acid analysis platforms. The company emphasizes workflow efficiency and scalability for single-cell sequencing and transcriptomic studies, supported by partnerships with sequencing technology providers. These initiatives are expanding the company’s capabilities in genomics and translational research.

single-cell-analysis-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 3.55 Billion
Market Forecast in 2030 (Value) USD 7.56 Billion
Growth Rate CAGR of 14.7% from 2025 to 2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product:
    • Consumables
    • Instruments
  • By Cell Type:
    • Human Cells
    • Animal Cells
    • Microbial Cells
  • By Technique:
    • Flow Cytometry
    • Next-generation Sequencing
    • Polymerase Chain Reaction
    • Microscopy
    • Mass Spectrometry
    • Other Techniques
  • By Application:
    • Research Applications
    • Medical Applications
  • By End User:
    • Academic & Research laboratories
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Diagnostic Laboratories
    • Cell Banks & IVF Centers
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: single-cell-analysis-market REPORT CONTENT GUIDE

single-cell-analysis-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Europe Single-cell Analysis Products Market
  • Country-level market estimation & forecast of European single-cell analysis market
  • Market growth trends analysis
  • Detailed Company Profiles of competitors
  • Enables prioritized market entry/expansion
  • Helps assess demand dynamics and identify high-growth opportunities.
Client Identification in North America & Europe
  • Competitive Profiling of Key Players
  • Client Identification in North America and Europe
  • Understanding of the competitive landscape
  • Supports client targeting, partnership strategies, and data-driven business decisions.

RECENT DEVELOPMENTS

  • February 2025 : The Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in Al model development in biology. CZI embarked on this landmark initiative in collaboration with partners 10x Genomics, Ultima Genomics, and leading researchers.
  • February 2025 : Oxford Nanopore Technologies announced its expanded collaboration with 10x Genomics, Inc. to enable seamless compatibility between their latest technologies. The certified compatibility was between 10x Genomics' latest Chromium Universal GEM-X 3' and GEM-X 5' single-cell chemistries, which enhance sensitivity while reducing cost per cell, and Oxford Nanopore's high-accuracy V14 chemistry.
  • October 2024 : 10x Genomics introduced two new Chromium products, GEM-X Flex and GEM-X Universal Multiplex, to make single-cell analysis more accessible and affordable for researchers.
  • October 2024 : BD launched the BD OMICS-One XT WTA Assay, a high-throughput, robotics-compatible reagent kit in collaboration with Hamilton Company (US). This solution reduces manual processes, improves consistency, minimizes variability, and accelerates large- scale single-cell discovery studies in areas like oncology and immunology.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
47
2
RESEARCH METHODOLOGY
 
 
 
52
3
EXECUTIVE SUMMARY
 
 
 
64
4
PREMIUM INSIGHTS
 
 
 
68
5
MARKET OVERVIEW
Explore how technological advancements and personalized medicine drive single-cell analysis market growth.
 
 
 
71
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS
 
 
 
 
5.2.1.2
RISING PREVALENCE OF CANCER
 
 
 
 
5.2.1.3
INCREASING R&D IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES
 
 
 
 
5.2.1.4
GROWTH IN STEM CELL RESEARCH
 
 
 
 
5.2.1.5
GROWING FOCUS ON PERSONALIZED MEDICINE
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH COST OF SINGLE-CELL ANALYSIS PRODUCTS
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
HIGH GROWTH POTENTIAL OF SINGLE-CELL SEQUENCING
 
 
 
 
5.2.3.2
INTEGRATION OF MICROFLUIDICS IN SINGLE-CELL ANALYSIS
 
 
 
 
5.2.3.3
RISING POTENTIAL IN EMERGING ASIAN MARKETS
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
LACK OF STANDARDIZATION IN PROTOCOLS AND QUALITY CONTROL PROCEDURES
 
 
 
 
5.2.4.2
TECHNICAL LIMITATIONS OF SINGLE-CELL ANALYSIS
 
 
 
 
5.2.4.3
MOUNTING ETHICAL AND PRIVACY CONCERNS
 
 
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.6
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.6.1
KEY TECHNOLOGIES
 
 
 
 
 
5.6.1.1
FLOW CYTOMETRY
 
 
 
 
5.6.1.2
NEXT-GENERATION SEQUENCING
 
 
 
 
5.6.1.3
POLYMERASE CHAIN REACTION
 
 
 
 
5.6.1.4
MICROSCOPY
 
 
 
 
5.6.1.5
MASS SPECTROMETRY
 
 
 
5.6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.6.2.1
BIOINFORMATICS TOOLS AND COMPUTATIONAL ANALYSIS
 
 
 
 
5.6.2.2
MULTI-OMICS INTEGRATION
 
 
 
5.6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.6.3.1
NANOTECHNOLOGY
 
 
 
 
5.6.3.2
ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
 
 
5.7
PATENT ANALYSIS
 
 
 
 
 
 
5.7.1
METHODOLOGY
 
 
 
 
5.7.2
PATENTS APPLIED AND GRANTED, 2014–2024
 
 
 
5.8
TRADE ANALYSIS
 
 
 
 
 
 
5.8.1
IMPORT DATA (HS CODE 9027)
 
 
 
 
5.8.2
EXPORT DATA (HS CODE 9027)
 
 
 
5.9
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.9.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.9.2
THREAT OF SUBSTITUTES
 
 
 
 
5.9.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.9.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.9.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.10
TARIFF & REGULATORY LANDSCAPE
 
 
 
 
 
5.10.1
TARIFF DATA (HS CODE 9027)
 
 
 
 
5.10.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
5.10.3
REGULATORY FRAMEWORK
 
 
 
5.11
PRICING ANALYSIS
 
 
 
 
 
 
5.11.1
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS
 
 
 
 
5.11.2
AVERAGE SELLING PRICE OF PRODUCTS, BY REGION
 
 
 
5.12
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
5.13
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.13.2
ROLE OF STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.13.3
BUYING CRITERIA
 
 
 
5.14
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.15
IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET
 
 
 
 
 
5.15.1
AI USE-CASES
 
 
 
 
5.15.2
KEY COMPANIES IMPLEMENTING AI
 
 
 
5.16
CASE STUDY ANALYSIS
 
 
 
 
 
5.16.1
COMPREHENSIVE SINGLE-CELL TRANSCRIPTOMIC ATLAS OF HUMAN CORNEA
 
 
 
 
5.16.2
MASSIVELY PARALLEL SINGLE-CELL RNA SEQUENCING IDENTIFIES RARE DRUG-RESISTANT CANCER SUBPOPULATIONS
 
 
 
 
5.16.3
SINGLE-CELL ANALYSIS OF RENAL CELL CARCINOMA REVEALS TUMOR HETEROGENEITY AND MICROENVIRONMENTAL COMPLEXITY
 
 
 
5.17
US 2025 TARIFF IMPACT OVERVIEW
 
 
 
 
 
5.17.1
INTRODUCTION
 
 
 
 
5.17.2
KEY TARIFF RATES
 
 
 
 
5.17.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.17.4
KEY IMPACT ON VARIOUS REGIONS
 
 
 
 
 
5.17.4.1
US
 
 
 
 
5.17.4.2
EUROPE
 
 
 
 
5.17.4.3
ASIA PACIFIC
 
 
 
 
5.17.4.4
REST OF THE WORLD
 
 
 
5.17.5
END-USE INDUSTRY IMPACT
 
 
 
 
 
5.17.5.1
PHARMACEUTICAL AND BIOTECH COMPANIES
 
 
 
 
5.17.5.2
CONTRACT RESEARCH ORGANIZATIONS (CROS)
 
 
 
 
5.17.5.3
ACADEMIC & RESEARCH INSTITUTES
 
6
SINGLE-CELL ANALYSIS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 73 Data Tables
 
 
 
122
 
6.1
INTRODUCTION
 
 
 
 
6.2
RESEARCH APPLICATIONS
 
 
 
 
 
6.2.1
CANCER RESEARCH
 
 
 
 
 
6.2.1.1
RISING PREVALENCE OF CANCER TO DRIVE MARKET
 
 
 
6.2.2
IMMUNOLOGY RESEARCH
 
 
 
 
 
6.2.2.1
HIGH INCIDENCE OF IMMUNOLOGICAL DISORDERS TO PROPEL MARKET
 
 
 
6.2.3
NEUROLOGY RESEARCH
 
 
 
 
 
6.2.3.1
INCREASING INCIDENCE OF NEUROLOGICAL DISORDERS TO BOOST MARKET
 
 
 
6.2.4
STEM CELL RESEARCH
 
 
 
 
 
6.2.4.1
RISING INVESTMENTS IN STEM CELL RESEARCH TO DRIVE MARKET
 
 
 
6.2.5
OTHER RESEARCH APPLICATIONS
 
 
 
6.3
MEDICAL APPLICATIONS
 
 
 
 
 
6.3.1
NON-INVASIVE PRENATAL DIAGNOSIS
 
 
 
 
 
6.3.1.1
INCREASING PREVALENCE OF GENETIC DISEASES TO DRIVE DEMAND
 
 
 
6.3.2
IN VITRO FERTILIZATION
 
 
 
 
 
6.3.2.1
GROWING DEMAND FOR IVF PROCEDURES TO SUPPORT MARKET
 
 
 
6.3.3
CIRCULATING TUMOR CELL DETECTION
 
 
 
 
 
6.3.3.1
RISING PREVALENCE OF CANCER TO CONTRIBUTE TO SEGMENT GROWTH
 
7
SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
 
 
 
155
 
7.1
INTRODUCTION
 
 
 
 
7.2
HUMAN CELLS
 
 
 
 
 
7.2.1
GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND
 
 
 
7.3
ANIMAL CELLS
 
 
 
 
 
7.3.1
INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
 
 
 
7.4
MICROBIAL CELLS
 
 
 
 
 
7.4.1
RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET
 
 
8
SINGLE-CELL ANALYSIS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 29 Data Tables
 
 
 
166
 
8.1
INTRODUCTION
 
 
 
 
8.2
ACADEMIC & RESEARCH LABORATORIES
 
 
 
 
 
8.2.1
INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
 
 
 
8.3
BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
 
 
 
 
 
8.3.1
GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET
 
 
 
8.4
HOSPITALS & DIAGNOSTIC LABORATORIES
 
 
 
 
 
8.4.1
HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND
 
 
 
8.5
CELL BANKS & IVF CENTERS
 
 
 
 
 
8.5.1
RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET
 
 
9
SINGLE-CELL ANALYSIS MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 130 Data Tables
 
 
 
182
 
9.1
INTRODUCTION
 
 
 
 
9.2
CONSUMABLES
 
 
 
 
 
9.2.1
BEADS
 
 
 
 
 
9.2.1.1
INCREASING USE IN RESEARCH AND GENETIC EXPLORATION TO DRIVE MARKET
 
 
 
9.2.2
MICROPLATES
 
 
 
 
 
9.2.2.1
RISING FREQUENCY OF PRODUCT LAUNCHES TO BOOST MARKET
 
 
 
9.2.3
REAGENTS
 
 
 
 
 
9.2.3.1
ADVANCEMENTS IN SINGLE-CELL GENOMICS TO INCREASE DEMAND
 
 
 
9.2.4
ASSAY KITS
 
 
 
 
 
9.2.4.1
IMMUNOASSAYS
 
 
 
 
9.2.4.2
CELL-BASED ASSAYS
 
 
 
9.2.5
OTHER CONSUMABLES
 
 
 
9.3
INSTRUMENTS
 
 
 
 
 
9.3.1
FLOW CYTOMETERS
 
 
 
 
 
9.3.1.1
TECHNOLOGICAL ADVANCEMENTS TO DRIVE DEMAND
 
 
 
9.3.2
NGS SYSTEMS
 
 
 
 
 
9.3.2.1
INCREASED AFFORDABILITY TO SUPPORT SEGMENT GROWTH
 
 
 
9.3.3
PCR INSTRUMENTS
 
 
 
 
 
9.3.3.1
RISING USE FOR DNA AND MRNA AMPLIFICATION TO BOOST MARKET
 
 
 
9.3.4
SPECTROPHOTOMETERS
 
 
 
 
 
9.3.4.1
TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET
 
 
 
9.3.5
CELL COUNTERS
 
 
 
 
 
9.3.5.1
RISING DEMAND FOR AUTOMATED CELL COUNTERS TO FUEL MARKET
 
 
 
9.3.6
MICROSCOPES
 
 
 
 
 
9.3.6.1
INCREASING USE IN CELL-BASED RESEARCH TO DRIVE MARKET
 
 
 
9.3.7
HCS SYSTEMS
 
 
 
 
 
9.3.7.1
GROWING NEED FOR MULTI-PARAMETRIC CELL ANALYSIS TO DRIVE ADOPTION
 
 
 
9.3.8
MICROARRAYS
 
 
 
 
 
9.3.8.1
INCREASING DEVELOPMENT OF TARGETED THERAPIES TO SUPPORT MARKET
 
 
 
9.3.9
OTHER INSTRUMENTS
 
 
10
SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 43 Data Tables
 
 
 
236
 
10.1
INTRODUCTION
 
 
 
 
10.2
FLOW CYTOMETRY
 
 
 
 
 
10.2.1
INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
 
 
 
10.3
NEXT-GENERATION SEQUENCING
 
 
 
 
 
10.3.1
WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET
 
 
 
10.4
POLYMERASE CHAIN REACTION
 
 
 
 
 
10.4.1
INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET
 
 
 
10.5
MICROSCOPY
 
 
 
 
 
10.5.1
FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET
 
 
 
10.6
MASS SPECTROMETRY
 
 
 
 
 
10.6.1
LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET
 
 
 
10.7
OTHER TECHNIQUES
 
 
 
11
SINGLE-CELL ANALYSIS MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 293 Data Tables.
 
 
 
257
 
11.1
INTRODUCTION
 
 
 
 
11.2
NORTH AMERICA
 
 
 
 
 
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
11.2.2
US
 
 
 
 
 
11.2.2.1
INCREASING R&D INVESTMENTS AND FUNDING TO DRIVE MARKET
 
 
 
11.2.3
CANADA
 
 
 
 
 
11.2.3.1
HIGH PREVALENCE OF HEMOPHILIA TO PROPEL MARKET
 
 
11.3
EUROPE
 
 
 
 
 
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
11.3.2
GERMANY
 
 
 
 
 
11.3.2.1
GROWING AWARENESS OF ADVANCED CELL THERAPIES TO SUPPORT MARKET
 
 
 
11.3.3
UK
 
 
 
 
 
11.3.3.1
GROWING ADOPTION OF SINGLE-CELL ANALYSIS PRODUCTS TO DRIVE DEMAND
 
 
 
11.3.4
FRANCE
 
 
 
 
 
11.3.4.1
GROWING GOVERNMENT FUNDING FOR R&D TO PROPEL MARKET
 
 
 
11.3.5
ITALY
 
 
 
 
 
11.3.5.1
FOCUS ON CELL BIOLOGY RESEARCH TO DRIVE MARKET
 
 
 
11.3.6
SPAIN
 
 
 
 
 
11.3.6.1
INCREASING NUMBER OF BIOTECHNOLOGY COMPANIES TO DRIVE DEMAND
 
 
 
11.3.7
REST OF EUROPE
 
 
 
11.4
ASIA PACIFIC
 
 
 
 
 
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
11.4.2
CHINA
 
 
 
 
 
11.4.2.1
INCREASING R&D EXPENDITURE TO SUPPORT MARKET
 
 
 
11.4.3
JAPAN
 
 
 
 
 
11.4.3.1
INCREASING GERIATRIC POPULATION TO FUEL DEMAND
 
 
 
11.4.4
INDIA
 
 
 
 
 
11.4.4.1
GROWING FOCUS ON DEVELOPMENT OF CELL-BASED THERAPIES TO BOOST MARKET
 
 
 
11.4.5
SOUTH KOREA
 
 
 
 
 
11.4.5.1
INCREASING NUMBER OF STRATEGIC ALLIANCES TO BOOST MARKET
 
 
 
11.4.6
AUSTRALIA
 
 
 
 
 
11.4.6.1
RISING NUMBER OF LIFE SCIENCE COMPANIES TO BOOST DEMAND
 
 
 
11.4.7
REST OF ASIA PACIFIC
 
 
 
11.5
LATIN AMERICA
 
 
 
 
 
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
11.5.2
BRAZIL
 
 
 
 
 
11.5.2.1
RISING FOCUS ON BIOTECHNOLOGY INDUSTRY TO BOLSTER MARKET
 
 
 
11.5.3
MEXICO
 
 
 
 
 
11.5.3.1
GOVERNMENT SUPPORT FOR BIOPHARMACEUTICAL PRODUCTION TO DRIVE MARKET
 
 
 
11.5.4
REST OF LATIN AMERICA
 
 
 
11.6
MIDDLE EAST
 
 
 
 
 
11.6.1
MACROECONOMIC OUTLOOK IN MIDDLE EAST
 
 
 
 
11.6.2
GCC
 
 
 
 
 
11.6.2.1
SAUDI ARABIA
 
 
 
 
11.6.2.2
UNITED ARAB EMIRATES
 
 
 
 
11.6.2.3
REST OF GCC
 
 
 
11.6.3
REST OF MIDDLE EAST
 
 
 
11.7
AFRICA
 
 
 
 
 
11.7.1
GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET
 
 
 
 
11.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
12
COMPETITIVE LANDSCAPE
Discover strategic shifts and market dominance among key players and emerging leaders.
 
 
 
381
 
12.1
OVERVIEW
 
 
 
 
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025
 
 
 
 
12.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
12.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
12.4.1
RANKING OF KEY MARKET PLAYERS
 
 
 
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
12.5.1
STARS
 
 
 
 
12.5.2
EMERGING LEADERS
 
 
 
 
12.5.3
PERVASIVE PLAYERS
 
 
 
 
12.5.4
PARTICIPANTS
 
 
 
 
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
12.5.5.1
COMPANY FOOTPRINT
 
 
 
 
12.5.5.2
PRODUCT FOOTPRINT
 
 
 
 
12.5.5.3
REGION FOOTPRINT
 
 
 
 
12.5.5.4
TECHNIQUE FOOTPRINT
 
 
 
 
12.5.5.5
APPLICATION FOOTPRINT
 
 
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
 
 
 
 
 
 
12.6.1
PROGRESSIVE COMPANIES
 
 
 
 
12.6.2
RESPONSIVE COMPANIES
 
 
 
 
12.6.3
DYNAMIC COMPANIES
 
 
 
 
12.6.4
STARTING BLOCKS
 
 
 
 
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
12.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
12.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
12.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
12.9
COMPETITIVE SCENARIO
 
 
 
 
 
12.9.1
PRODUCT LAUNCHES
 
 
 
 
12.9.2
DEALS
 
 
 
 
12.9.3
EXPANSIONS
 
 
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
408
 
13.1
INTRODUCTION
 
 
 
 
13.2
KEY PLAYERS
 
 
 
 
 
13.2.1
BD
 
 
 
 
 
13.2.1.1
BUSINESS OVERVIEW
 
 
 
 
13.2.1.2
PRODUCTS OFFERED
 
 
 
 
13.2.1.3
RECENT DEVELOPMENTS
 
 
 
 
13.2.1.4
MNM VIEW
 
 
 
13.2.2
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
13.2.3
DANAHER CORPORATION
 
 
 
 
13.2.4
10X GENOMICS
 
 
 
 
13.2.5
MERCK KGAA
 
 
 
 
13.2.6
AGILENT TECHNOLOGIES, INC.
 
 
 
 
13.2.7
QIAGEN
 
 
 
 
13.2.8
ILLUMINA, INC.
 
 
 
 
13.2.9
BIO-RAD LABORATORIES, INC.
 
 
 
 
13.2.10
DIASORIN S.P.A.
 
 
 
 
13.2.11
STANDARD BIOTOOLS
 
 
 
 
13.2.12
TECAN TRADING AG
 
 
 
 
13.2.13
SARTORIUS AG
 
 
 
 
13.2.14
CORNING INCORPORATED
 
 
 
 
13.2.15
CYTEK BIOSCIENCES
 
 
 
 
13.2.16
TAKARA BIO INC.
 
 
 
 
13.2.17
BIOMÉRIEUX
 
 
 
 
13.2.18
REVVITY
 
 
 
 
13.2.19
BIO-TECHNE
 
 
 
 
13.2.20
PACBIO
 
 
 
 
13.2.21
BRUKER
 
 
 
 
13.2.22
PROMEGA CORPORATION
 
 
 
 
13.2.23
OXFORD NANOPORE TECHNOLOGIES PLC
 
 
 
13.3
OTHER PLAYERS
 
 
 
 
 
13.3.1
SINGLERON BIOTECHNOLOGIES
 
 
 
 
13.3.2
CELL MICROSYSTEMS
 
 
 
 
13.3.3
NANOCELLECT BIOMEDICAL
 
 
 
 
13.3.4
RARECYTE, INC.
 
 
 
 
13.3.5
BICO
 
 
 
 
13.3.6
MENARINI GROUP
 
 
 
 
13.3.7
APOGEE FLOW SYSTEMS LTD
 
 
 
 
13.3.8
CREATIVE BIOLABS
 
 
 
 
13.3.9
SPHERE BIO
 
 
 
 
13.3.10
YOKOGAWA ELECTRIC CORPORATION
 
 
14
APPENDIX
 
 
 
508
 
14.1
DISCUSSION GUIDE
 
 
 
 
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
14.3
CUSTOMIZATION OPTIONS
 
 
 
 
14.4
RELATED REPORTS
 
 
 
 
14.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
TABLE 2
SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS
 
 
 
 
TABLE 3
RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES
 
 
 
 
TABLE 4
PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
 
 
 
 
TABLE 5
PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
 
 
 
 
TABLE 6
ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019–2025
 
 
 
 
TABLE 7
SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS
 
 
 
 
TABLE 8
SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS
 
 
 
 
TABLE 9
SINGLE-CELL ANALYSIS MARKET: END USERS
 
 
 
 
TABLE 10
SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES
 
 
 
 
TABLE 11
APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS
 
 
 
 
TABLE 12
TYPES OF BIOINFORMATICS TOOLS
 
 
 
 
TABLE 13
PATENTS FILED, 2014–2024
 
 
 
 
TABLE 14
INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024
 
 
 
 
TABLE 15
IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
TABLE 16
IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
 
 
 
 
TABLE 17
EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
TABLE 18
EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (TONS)
 
 
 
 
TABLE 19
SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 20
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 21
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 22
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 23
ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 24
SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES
 
 
 
 
TABLE 25
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022–2024
 
 
 
 
TABLE 26
AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
 
 
 
 
TABLE 27
SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
TABLE 28
BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER
 
 
 
 
TABLE 29
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 30
KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS AND ELECTRICAL MACHINERY AND EQUIPMENT AND PARTS THEREOF
 
 
 
 
TABLE 31
CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES
 
 
 
 
TABLE 32
SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 40
GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 50
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 52
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 58
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 60
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 68
GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 92
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 96
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 107
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 167
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 170
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 175
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 176
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 184
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 185
GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 186
SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 188
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 190
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 193
GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 194
SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 202
NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 203
EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 208
SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 211
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 212
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 213
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 220
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 223
SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 229
GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 236
GCC: SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 237
SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
GCC: SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 244
SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 245
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
GCC: SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 252
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 260
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 262
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 268
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
GCC: SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 276
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 280
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 284
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 285
GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 286
SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 287
SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 288
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 289
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 290
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 291
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 292
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 293
GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 294
SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 295
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 296
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 297
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 298
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 299
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 300
GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 301
SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 302
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 303
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 304
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 305
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 306
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 307
GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 308
SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 309
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 310
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 311
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 312
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 313
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 314
GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 315
SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 316
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 317
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 318
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 319
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 320
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 321
GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 322
SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 323
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 324
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 325
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 326
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 327
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 328
GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 329
SINGLE-CELL ANALYSIS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 330
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 331
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 332
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 333
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 334
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 335
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 336
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 337
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 338
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 339
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 340
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 341
NORTH AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 342
US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 343
US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 344
US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 345
US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 346
US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 347
US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 348
US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 349
US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 350
US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 351
US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 352
CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 353
CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 354
CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 355
CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 356
CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 357
CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 358
CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 359
CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 360
CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 361
CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 362
EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 363
EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 364
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 365
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 366
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 367
EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 368
EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 369
EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 370
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 371
EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 372
EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 373
EUROPE: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 374
GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 375
GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 376
GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 377
GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 378
GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 379
GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 380
GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 381
GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 382
GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 383
GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 384
UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 385
UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 386
UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 387
UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 388
UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 389
UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 390
UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 391
UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 392
UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 393
UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 394
FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 395
FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 396
FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 397
FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 398
FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 399
FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 400
FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 401
FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 402
FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 403
FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 404
ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 405
ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 406
ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 407
ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 408
ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 409
ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 410
ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 411
ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 412
ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 413
ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 414
SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 415
SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 416
SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 417
SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 418
SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 419
SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 420
SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 421
SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 422
SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 423
SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 424
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 425
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 426
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 427
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 428
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 429
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 430
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 431
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 432
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 433
REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 434
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 435
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 436
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 437
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 438
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 439
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 440
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 441
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 442
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 443
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 444
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 445
ASIA PACIFIC: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 446
CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 447
CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 448
CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 449
CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 450
CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 451
CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 452
CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 453
CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 454
CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 455
CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 456
JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 457
JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 458
JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 459
JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 460
JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 461
JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 462
JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 463
JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 464
JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 465
JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 466
INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 467
INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 468
INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 469
INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 470
INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 471
INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 472
INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 473
INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 474
INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 475
INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 476
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 477
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 478
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 479
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 480
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 481
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 482
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 483
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 484
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 485
SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 486
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 487
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 488
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 489
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 490
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 491
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 492
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 493
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 494
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 495
AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 496
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 497
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 498
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 499
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 500
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 501
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 502
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 503
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 504
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 505
REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 506
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 507
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 508
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 509
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 510
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 511
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 512
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 513
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 514
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 515
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 516
LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 517
LATIN AMERICA: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 518
BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 519
BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 520
BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 521
BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 522
BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 523
BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 524
BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 525
BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 526
BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 527
BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 528
MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 529
MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 530
MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 531
MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 532
MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 533
MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 534
MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 535
MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 536
MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 537
MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 538
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 539
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 540
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 541
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 542
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 543
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 544
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 545
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 546
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 547
REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 548
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 549
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 550
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 551
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 552
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 553
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 554
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 555
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 556
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 557
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 558
MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 559
MIDDLE EAST: MACROECONOMIC INDICATORS
 
 
 
 
TABLE 560
GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 561
GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 562
GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 563
GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 564
GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 565
GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 566
GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 567
GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 568
GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 569
GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 570
GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 571
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 572
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 573
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 574
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 575
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 576
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 577
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 578
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 579
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 580
SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 581
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 582
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 583
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 584
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 585
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 586
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 587
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 588
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 589
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 590
UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 591
REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 592
REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 593
REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 594
REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 595
REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 596
REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 597
REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 598
REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 599
REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 600
REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 601
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 602
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 603
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 604
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 605
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 606
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 607
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 608
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 609
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 610
REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 611
AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 612
AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 613
AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 614
AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 615
AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 616
AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 617
AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 618
AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 619
AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 620
AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 621
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
 
 
TABLE 622
SINGLE-CELL ANALYSIS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025
 
 
 
 
TABLE 623
SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 624
SINGLE-CELL ANALYSIS MARKET: PRODUCT FOOTPRINT
 
 
 
 
TABLE 625
SINGLE-CELL ANALYSIS MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 626
SINGLE-CELL ANALYSIS MARKET: TECHNIQUE FOOTPRINT
 
 
 
 
TABLE 627
SINGLE-CELL ANALYSIS MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 628
SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 629
SINGLE-CELL ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 630
SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 631
SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 632
SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 633
BD: COMPANY OVERVIEW
 
 
 
 
TABLE 634
BD: PRODUCTS OFFERED
 
 
 
 
TABLE 635
BD: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 636
BD: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 637
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 638
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 639
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 640
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 641
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 642
DANAHER CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 643
DANAHER CORPORATION: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 644
10X GENOMICS: COMPANY OVERVIEW
 
 
 
 
TABLE 645
10X GENOMICS: PRODUCTS OFFERED
 
 
 
 
TABLE 646
10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 647
10X GENOMICS: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 648
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
TABLE 649
MERCK KGAA: PRODUCTS OFFERED
 
 
 
 
TABLE 650
MERCK KGAA: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 651
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 652
AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 653
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 654
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 655
QIAGEN: COMPANY OVERVIEW
 
 
 
 
TABLE 656
QIAGEN: PRODUCTS OFFERED
 
 
 
 
TABLE 657
QIAGEN: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 658
ILLUMINA, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 659
ILLUMINA, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 660
ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 661
ILLUMINA, INC.: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 662
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 663
BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 664
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 665
DIASORIN S.P.A.: COMPANY OVERVIEW
 
 
 
 
TABLE 666
DIASORIN S.P.A.: PRODUCTS OFFERED
 
 
 
 
TABLE 667
DIASORIN S.P.A.: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 668
STANDARD BIOTOOLS: COMPANY OVERVIEW
 
 
 
 
TABLE 669
STANDARD BIOTOOLS: PRODUCTS OFFERED
 
 
 
 
TABLE 670
STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 671
STANDARD BIOTOOLS: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 672
TECAN TRADING AG: COMPANY OVERVIEW
 
 
 
 
TABLE 673
TECAN TRADING AG: PRODUCTS OFFERED
 
 
 
 
TABLE 674
TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 675
TECAN TRADING AG: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 676
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
TABLE 677
SARTORIUS AG: PRODUCTS OFFERED
 
 
 
 
TABLE 678
SARTORIUS AG: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 679
SARTORIUS AG: EXPANSIONS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 680
CORNING INCORPORATED: COMPANY OVERVIEW
 
 
 
 
TABLE 681
CORNING INCORPORATED: PRODUCTS OFFERED
 
 
 
 
TABLE 682
CYTEK BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 683
CYTEK BIOSCIENCES: PRODUCTS OFFERED
 
 
 
 
TABLE 684
CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 685
CYTEK BIOSCIENCES: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 686
CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 687
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 688
TAKARA BIO INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 689
TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 690
TAKARA BIO INC.: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 691
BIOMÉRIEUX: COMPANY OVERVIEW
 
 
 
 
TABLE 692
BIOMÉRIEUX: PRODUCTS OFFERED
 
 
 
 
TABLE 693
BIOMÉRIEUX: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 694
REVVITY: COMPANY OVERVIEW
 
 
 
 
TABLE 695
REVVITY: PRODUCTS OFFERED
 
 
 
 
TABLE 696
REVVITY: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 697
BIO-TECHNE: COMPANY OVERVIEW
 
 
 
 
TABLE 698
BIO-TECHNE: PRODUCTS OFFERED
 
 
 
 
TABLE 699
BIO-TECHNE: DEALS
 
 
 
 
TABLE 700
PACBIO: COMPANY OVERVIEW
 
 
 
 
TABLE 701
PACBIO: PRODUCTS OFFERED
 
 
 
 
TABLE 702
PACBIO: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 703
BRUKER: COMPANY OVERVIEW
 
 
 
 
TABLE 704
BRUKER: PRODUCTS OFFERED
 
 
 
 
TABLE 705
BRUKER: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 706
BRUKER: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 707
PROMEGA CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 708
PROMEGA CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 709
OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
 
 
 
 
TABLE 710
OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED
 
 
 
 
TABLE 711
OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021–APRIL 2025
 
 
 
 
TABLE 712
SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
TABLE 713
CELL MICROSYSTEMS: COMPANY OVERVIEW
 
 
 
 
TABLE 714
NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 715
RARECYTE, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 716
BICO: COMPANY OVERVIEW
 
 
 
 
TABLE 717
MENARINI GROUP: COMPANY OVERVIEW
 
 
 
 
TABLE 718
APOGEE FLOW SYSTEMS LTD: COMPANY OVERVIEW
 
 
 
 
TABLE 719
CREATIVE BIOLABS: COMPANY OVERVIEW
 
 
 
 
TABLE 720
SPHERE BIO: COMPANY OVERVIEW
 
 
 
 
TABLE 721
YOKOGAWA ELECTRIC CORPORATION: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
SINGLE-CELL ANALYSIS MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 2
BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET
 
 
 
 
FIGURE 3
SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
 
 
 
 
FIGURE 4
MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
 
 
 
 
FIGURE 5
ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2024
 
 
 
 
FIGURE 6
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
FIGURE 7
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
FIGURE 8
SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS
 
 
 
 
FIGURE 9
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 10
SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 11
SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 12
SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 13
SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 14
SINGLE-CELL ANALYSIS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET
 
 
 
 
FIGURE 16
GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET
 
 
 
 
FIGURE 17
HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2024
 
 
 
 
FIGURE 18
CONSUMABLES SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2025
 
 
 
 
FIGURE 19
ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 20
ASIA PACIFIC COUNTRIES TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 21
SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 22
AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN MEN AND WOMEN, 2022
 
 
 
 
FIGURE 23
WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014–2028
 
 
 
 
FIGURE 24
SHARE OF PERSONALIZED MEDICINE IN FDA'S NEW DRUG APPROVALS, 2015–2023
 
 
 
 
FIGURE 25
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
FIGURE 26
SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 27
SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 28
PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET, JANUARY 2014–DECEMBER 2024
 
 
 
 
FIGURE 29
SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 30
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
 
 
 
 
FIGURE 31
KEY BUYING CRITERIA FOR END USERS
 
 
 
 
FIGURE 32
SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, 2023–2030 (THOUSAND UNITS)
 
 
 
 
FIGURE 33
NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
 
 
 
 
FIGURE 34
NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025
 
 
 
 
FIGURE 35
ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
 
 
 
 
FIGURE 36
REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2022–2024
 
 
 
 
FIGURE 37
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
 
 
 
 
FIGURE 38
RANKING OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2024
 
 
 
 
FIGURE 39
SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 40
SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 41
SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023
 
 
 
 
FIGURE 42
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 43
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 44
SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 45
BD: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 46
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 47
DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 48
10X GENOMICS: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 49
MERCK KGAA: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 50
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 51
QIAGEN: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 52
ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 53
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 54
DIASORIN S.P.A.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 55
STANDARD BIOTOOLS: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 56
TECAN TRADING AG: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 57
SARTORIUS AG: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 58
CORNING INCORPORATED: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 59
CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 60
TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 61
BIOMÉRIEUX: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 62
REVVITY: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 63
BIO-TECHNE: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 64
PACBIO: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 65
BRUKER: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 66
OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-cell analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), and Society for Laboratory Automation and Screening (SLAS), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global single-cell analysis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks, and IVF centers, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Single-Cell Analysis Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the single-cell analysis business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Top-down Approach

  • After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Single-Cell Analysis Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Single-cell analysis is a method for examining individual cells across various parameters, particularly beneficial when dealing with diverse cell populations. This approach focuses on studying a single cell isolated from tissues in a multicellular organism. Technologies including flow cytometry and microfluidics are used for single-cell analysis purpose. Such analysis facilitates the exploration of variations between cells within a population. Currently, single-cell analysis finds extensive applications in cancer research, immunology, stem cell research, and neurobiology.

Stakeholders

  • Single-cell analysis product manufacturers, vendors, and distributors
  • Academic and research laboratories
  • Pharmaceutical and biopharmaceutical companies
  • Venture capitalists and investors
  • Government organizations
  • Private research firms
  • Cell Banks & IVF centers
  • Hospitals & diagnostic centers

Report Objectives

  • To define, describe, segment, and forecast the single-cell analysis market by product, cell type, technique, application, end user, and region
  • To provide detailed information about the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-cell analysis market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
  • To strategically profile the key players in the global single-cell analysis market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments in the single-cell analysis market, such as product launches, acquisitions, collaborations, expansions, and partnerships
  • To benchmark players within the single-cell analysis market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business excellence and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.
Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
  • A further breakdown of the Rest of Europe  single-cell analysis market into countries
  • A further breakdown of the Rest of Asia Pacific single-cell analysis market into countries
  • A further breakdown of the Rest of Latin American single-cell analysis market into countries
  • A further breakdown of the Rest of Middle East single-cell analysis market into countries

Key Questions Addressed by the Report

Who are the key players in the single-cell analysis market?
Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), 10X Genomics (US), and BD (US).
Which product segment dominates the single-cell analysis market?
The consumables segment, due to the increasing need for high-quality reagents for developing advanced biotherapeutic products.
Which cell type segment is expected to witness the highest growth?
The human cells segment, driven by the rising demand for cell-based therapies and the prevalence of chronic diseases.
Which application segment is expected to register the highest growth?
The research applications segment, fueled by the increasing need for advanced biotherapeutics.
What is the size of the single-cell analysis market?
Expected to grow at a CAGR of 14.7%, from approximately USD 3.81 billion in 2025 to USD 7.56 billion by 2030.

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Single Cell Analysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Single Cell Analysis Market

DMCA.com Protection Status